Browse News
Filter News
Found 530,084 articles
-
Gilead Sciences officially announced that long-time Roche veteran, Daniel O’Day, will assume the helm of the company as chairman and chief executive officer beginning March 1. O'Day takes over for John Milligan, who announced his plans to retire by the end of the year in July.
-
There is very little doubt that developing drugs for neuroscience disorders in general and dementias in particular is a high-risk business. Axovant Sciences, unfortunately, seems to be finding that out the hard way.
-
At its San Diego site, the company plans to establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D, which will also include Phase I GMP manufacturing.
-
What’s Going on With the Biosimilar Market?
12/10/2018
Although a moderate presence in Europe, with about 25 biosimilars approved and on the market, they haven’t gained traction in the U.S. Even though at least 11 have been approved in the U.S., only about three are available, largely because of business tactics branded drug companies are using to sl... -
This morning the Pharmaceutical Research and Manufacturers of America (PhRMA) released a report that shows there are nearly 300 novel cell and gene therapies currently in development throughout the industry. The therapies are being studied as treatments for a variety of diseases and conditions.
-
New Report Shows More Failures to Disclose Potential Conflicts of Interest in Journal Articles
12/10/2018
More journal articles are revealed to lack full disclosure of the authors' ties to the pharmaceutical industry. -
BioSpace Movers and Shakers for Dec. 10
12/10/2018
Biotech and pharma companies strengthen their leadership teams with these appointments. Who made power moves in the industry this past week? -
It apparently began with a 2016 federal lawsuit. At that time, 20 state attorneys general filed a federal lawsuit alleging that six generic drug makers artificially inflated and manipulated prices for an antibiotic and an oral diabetes drug. The goal was to reduce competition.
-
Biomimicry, looking at how things are done in nature and applying that to solve problems, is utilized by many researchers. BioSpace looks at some examples of how scientists are performing cutting-edge research using biomimicry.
-
Many recent college graduates with science degrees wonder, “What other careers are available outside of a laboratory or research environment?” Concurrently, a large amount of mid-career and late-career professionals consider pursuing non-traditional science roles.
-
The Genome of Giant Tortoise "Lonesome George" Provides Clues to Longevity and Disease Resistance
12/10/2018
Researchers published an article in the journal Nature Ecology & Evolution today that described preliminary findings of gene variants in George associated with a strong immune system, efficient DNA repair and cancer resistance. -
WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel Bispecific Antibody Immunotherapeutics
12/10/2018
WuXi Biologics announced today a strategic collaboration with Brii Biosciences
-
Maria Sophocles, M.D. Provides 2019 Health Forecast
12/10/2018
As we head into 2019, Maria Sophocles, M.D., OB/GYN at Women’s Healthcare of Princeton, reminds us not to believe every trend a celebrity touts, and describes what’s new as well as tried and true solutions to recurring, embarrassing health issues and new technology to keep us safe and more comfortable as we age.
-
American Academy of Ophthalmology Calls on States to Maintain High Safety Standards for Surgical Eye Care
12/10/2018
The American Academy of Ophthalmology agrees with important patient safety guidelines recommended in a joint report issued by the three federal agencies that help guide the nation's health care system.
-
Immunovative Therapies to Present at Biotech Showcase™ 2019 in San Francisco
12/10/2018
Immunovative Therapies, Ltd. today announced that it will present at Biotech Showcase™ 2019, to be held January 7–9 at the Hilton San Francisco Union Square.
-
MilliporeSigma and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models
12/10/2018
MilliporeSigma, a leader in genome editing, today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway.
-
Hospital-Based Radiology Group Taking Over the Arizona Market
12/10/2018
Medical Diagnostic Imaging Group (MDIG) continues to expand in its home state of Arizona. MDIG announced that they have partnered with St. Luke's Medical Center locations to include; Tempe St. Luke's Hospital, St.
-
Varian Named One of America's Most Just Companies in 2018 by Forbes and JUST Capital
12/10/2018
Varian (NYSE: VAR) today announced it was named one of America's Most JUST Companies in 2018, according to the JUST Capital and Forbes magazine JUST 100 List.
-
SQI Diagnostics' Direct-to-Consumer Partner Launches At-Home Celiac Disease Awareness Test
12/10/2018
SQI Diagnostics Inc. (TSX-V: SQD; OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI" or the "Company"), today announces the launch of the imaware™ at-home test for celiac disease by its partner, Microdrop. imaware
-
OneOncology to Add Former U.S. Senate Majority Leader Sen. Bill Frist to Board of Directors
12/10/2018
OneOncology announced the election of former U.S. Senate Majority Leader, Bill Frist to its board of directors.